The pathogenesis of myeloproliferative disorder remains unknown, but there have been some experiments on murine myeloproliferative sarcoma induced by certain viruses.
( Table 2) .
Peripheral blood, bone marrow cells and spleen cells were examined cytochemically, including peroxidase, acethylcholine esterase, naphthol-ASD-chloroacetate estarase, and naphthol-AS-acetate esterase with or without inhibition by sodium floride.
Results
In the first experimental group, only one rat inoculated on the 17th day after 3. Erythroleukemia (EL): similar to AML, but some differentiation to erythro blast, or mixed with erythroid precursor cells.
MPD developed in 14 rats and was relatively concentrated in the early stage of the experiment. The average date of MPD development was the 21st day. The spleen generally showed moderate enlargement with marked proliferation of granulocytes, erythroblasts and megakaryocytes mixed with blast cells. In some cases, several blast foci also appeared. The liver showed slight infiltration of blast cells. Histological changes of bone marrow were similar to the spleen, though much less severe. No remarkable increase of reticulin fibers was observed.
Peripheral blood counts revealed marked leukopenia in 5/7, marked anemia in 6/7 and thrombocytopenia in 3/7 rats. Thrombocythemia was observed in 1/7. Acute non lymphocytic leukemias developed in 11 rats and were subdivided to 8 cases of erythroleu kemia and 3 cases of acute myeloblastic leukemia. They developed between the 19-38th day after inoculation (average 29th day). The spleen showed moderate to marked enlargement with diffuse proliferation of blast cells, whereas the bone marrow showed much less infiltration of blast cells. Monotonous dence infiltration of blast cells was lacking in the bone marrow. The liver had small foci of blast cells. Peripheral blood counts revealed marked leukopenia in 4/9, marked anemia in 6/9 and thrombocytopenia in 4/9 rats, and leukocytosis was observed in 2/9 rats.
In all MPDs, AMLs and ELs, blast cells appeared in the peripheral blood, thymus and lymph-nodes, more or less.
Angiosarcomas developed in 15 rats among 28 rats of the secondary group, and all of them were exclusively concentrated after the 24th day, and after the 24th day all of the rats in this group developed angiosarcoma in the central nervous system, mainly in the cerebellum. Angiosarcoma of the spleen developed in the last two rats in this group, sacrificed on the 38th and 46th day after inoculation.
Discussion
The myeloproliferative sarcoma virus (MPSV) was derived by passage of Moloney sarcoma virus (Mo-MuSV) in adult mice.
The variants of Mo-MuSV form a family of replication-defective tumor viruses which transform fibroblast.7,8 They commonly share the mos-gene, an endogenous sequence of mice, acquired by recombination with replication-competent Moloney murine leukemia virus (Mo-MuLV) at the cost of a major part of the env-region and some part of the pol-gene9, 10 Whereas In our studies, Jar-2 rats inoculated with MPSV/helper F-MuLV complex at the newborn stage developed hemopoietic tumors, most prominent in the spleen, and angio sarcoma of the brain, spinal cord, and spleen in later stages of the experiment.
Inoculation of Jar-2 rats with only F-MuLV by the same way however caused no hemopoietic or angiomatous tumors (unpublished data). So we think that MPSV has a unique property of inducing hemopoietic and angiomatous tumors in newborn Jar-2 rats.
All 25 rats among those inoculated at the newborn stage, and sacrificed after the 14th day of the experiment developed hemopoietic tumors, and all 15 rats sacrificed after the 24th day developed angiosarcomas, so it could be summarized that all rats inoculated at the newborn stage will develop hemopoietic sarcoma and angiosarcoma following a certain incubation period. Hemopoietic sarcoma will develop later than two weeks after the inoculation, and angiosarcoma will develop later than three weeks after the inoculation.
Inoculation to adult rats will not induce sarcomas, where 17 days after birth seems to be a time limit for inoculation.
All the hemopoietic tumors belonged to non-lymphocytic leukemias, and were subdivided into three classes; 1. Myeloproliferative disorder (MPD), 2. Acute myelo blastic leukemia (AML), and 3. Erythroleukemia (EL).
MPD is characterized by marked proliferation of trilineages of hematopoietic cells with various amounts of immature cells. AML and EL belong to acute leukemia. In our experiment, cases of MPD were relatively concentrated in the earlier stage as com pared to AMLs and ELs. It might be possible that acute leukemias developed through MPD stages, but it will require further studies for that proof. The Majority of cases showed severe anemia, leukopenia and thrombocytopenia with the appearance of im mature cells in peripheral blood, and these findings reminded us of myelodysplastic syndromes in human cases (MDS or hemopoietic dysplasia) and of acute leukemia developed through MDS, rather than chronic myelogenous leukemia or other myelopro liferative disorders.
Myeloproliferative sarcoma virus might be useful for studies of myeloproliferative disorders, not only in mice but also in rats.
